The mylife
™
Unio
™
Neva blood glucose monitoring system is intended for in-vitro (outside the
body) diagnostic use for self-testing. The coding of the test strips is automatically detected.
The test result is plasma equivalent and achieved by using (a) fresh capillary whole blood that
may be drawn from the fingertip, palm or forearm, (b) venous whole blood samples and (c)
arterial whole blood samples.
You may consult your healthcare professional for instructions on how to use the system
correctly. Our customer support staff are available to assist you.
Healthcare professionals may use the mylife
™
Unio
™
Neva blood glucose monitoring system
for surveillance of the blood glucose levels of patients in medical facilities.
For a better understanding of this user guide, the mylife
™
Unio
™
Neva blood glucose monitoring
system will be referred to as BGMS; the mylife
™
Unio
™
Neva blood glucose meter as
meter; the mylife
™
SoftCase as SoftCase; the mylife
™
Unio
™
test strips as test strips; the mylife
™
AutoLance
™
lancing device as lancing device; the mylife
™
Lancets as lancets; the mylife
™
ControlGDH control solution as control solution; the mylife
™
App/mylife
™
Software as app
and the smartphone or personal computer as mobile device.
Intended use
6